Novotech
Novotech, officially known as Novotech Health, is a leading contract research organisation (CRO) headquartered in the United States, with significant operations across North America and Asia-Pacific. Founded in 1996, Novotech has established itself as a key player in the clinical research industry, specialising in providing comprehensive services for biotechnology and pharmaceutical companies. The company offers a unique blend of clinical development services, including Phase I-IV clinical trials, regulatory affairs, and data management, distinguished by its deep regional expertise and a strong focus on customer collaboration. Novotech's commitment to innovation and quality has earned it a prominent market position, recognised for its ability to accelerate drug development timelines while maintaining rigorous standards. With a track record of successful partnerships and notable achievements, Novotech continues to drive advancements in the clinical research landscape.
DitchCarbon Score
How does Novotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novotech's score of 13 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Novotech's reported carbon emissions
Novotech, headquartered in the US, has set ambitious climate commitments aimed at significantly reducing its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established a clear framework for its sustainability goals. Novotech aims to achieve a 38% reduction in its greenhouse gas emissions from a 2021 baseline by 2030, encompassing all scopes of emissions (Scope 1, 2, and 3). Furthermore, the company has committed to reaching Net Zero emissions by 2050. These targets reflect Novotech's dedication to addressing climate change and aligning with industry standards for sustainability. The company has already made strides in its efforts, particularly in reducing Scope 2 emissions to zero through the use of renewable energy credits. This initiative underscores Novotech's proactive approach to mitigating its environmental impact and contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
